approved

Приложение 4 на ПЛС от 02.10.2020 г.

Unique identificator:  9c8162ef-5c30-4c3c-ae8b-09bec0f8f412

Description:

Приложение 4 на ПЛС от 02.10.2020 г.

РМС 214/2016

Current version: 2

Displayed version: 1

Format: CSV

  • Created at: 2020-10-05 14:44:21
  • Created by: georgi_sivchev
  • Updated at: 2020-10-15 10:22:27
  • Updated by: georgi_sivchev
records per page
Order by:

ПОЗИТИВЕН ЛЕКАРСТВЕН СПИСЪК

Rasagiline 20160015 Sagilia, Tablet, 1, mg, Pack: 30 Medochemie Ltd., Кипър Medochemie Ltd., Factory AZ, Limassol, Кипър 77.26 15.45 92.71 4% 3.09 80.35 16.07 96.42 16% 12.36 92.71 18.54 111.25 НСР-8539/24.03.2016 и НСР-8660/01.04.2016 (допуска предварително изпълнение); КП-20/11.04.2017 и НСР-11215/15.12.2016; НСР-14042/02.10.2017 02.05.2017 02.11.2017 Заличен 4214
Rasagiline 20160015 Sagilia, Tablet, 1, mg, Pack: 30 Medochemie Ltd., Кипър Medochemie Ltd., Factory AZ, Limassol, Кипър 77.26 15.45 92.71 4% 3.09 80.35 16.07 96.42 16% 12.36 92.71 18.54 111.25 НСР-8539/24.03.2016 и НСР-8660/01.04.2016 (допуска предварително изпълнение); КП-20/11.04.2017 и НСР-11215/15.12.2016 02.05.2017 02.05.2017 Неактивен 4214
Rasagiline 20160015 Sagilia, Tablet, 1, mg, Pack: 30 Medochemie Ltd., Кипър Medochemie Ltd., Factory AZ, Limassol, Кипър 122.45 24.49 146.94 4% 4.9 127.35 25.47 152.82 16% 19.59 146.94 29.39 176.33 НСР-8539/24.03.2016 и НСР-8660/01.04.2016 (допуска предварително изпълнение) 02.04.2016 02.04.2016 Неактивен 4214
Sulfasalazine II-4492/18.03.2009 SALAZOPYRIN EN, Gastro resistant tablet, 500, mg, Pack: 100 Pfizer Enterprises SARL, Люксембург Kemwell AB - Sweden 9.31 1.86 11.17 7% 0.65 9.96 1.99 11.95 20% 1.86 11.82 2.36 14.18 Цената се заличава с решение НСР-3790/16.06.2014 ( в сила от 16.07.2014) КЦРР-2203/06.02.2013 03.03.2013 03.03.2013 Заличен 1652
Sulfasalazine II-4492/18.03.2009 SALAZOPYRIN EN, Gastro resistant tablet, 500, mg, Pack: 100 Pfizer Enterprises SARL, Люксембург Kemwell AB - Sweden 13.2 2.64 15.84 6% 0.79 13.99 2.8 16.79 18% 2.38 16.37 3.27 19.64 КЦ-826/15.04.2009 30.04.2009 30.04.2009 Неактивен 1652
Salbutamol 20030690 SALBUTAMOL INHALER, Pressurised inhalation, suspension, 100 mcg/metered actuation - 200 doses, mg, Pack: 1 GlaxoSmithKline (Ireland) Limited, Ирландия Glaxo Wellcome Production, France; GlaxoSmith Kline Pharmaceuticals S.A. Poland; Glaxo Wellcome S.A., Spain 2.8 0.56 3.36 7% 0.2 3 0.6 3.6 20% 0.56 3.56 0.71 4.27 Промяна на обстоятелства НСР-18242/22.03.2019 НСР-2429/21.01.2014; НСР-12563/05.05.2017; НСР-15953/22.06.2018 07.07.2018 02.05.2019 Активен 2452
Salbutamol 20030690 SALBUTAMOL INHALER, Pressurised inhalation, suspension, 100 mcg/metered actuation - 200 doses, mg, Pack: 1 Glaxo Group Ltd., Обединено Кралство Glaxo Wellcome Production, France; GlaxoSmith Kline Pharmaceuticals S.A. Poland; Glaxo Wellcome S.A., Spain 2.8 0.56 3.36 7% 0.2 3 0.6 3.6 20% 0.56 3.56 0.71 4.27 НСР-2429/21.01.2014; НСР-12563/05.05.2017; НСР-15953/22.06.2018 07.07.2018 02.08.2018 Неактивен 2452
Salbutamol 20030690 SALBUTAMOL INHALER, Pressurised inhalation, suspension, 100 mcg/metered actuation - 200 doses, mg, Pack: 1 Glaxo Group Ltd., Обединено Кралство Glaxo Wellcome Production, France; GlaxoSmith Kline Pharmaceuticals S.A. Poland; Glaxo Wellcome S.A., Spain 2.99 0.6 3.59 7% 0.21 3.2 0.64 3.84 20% 0.6 3.8 0.76 4.56 НСР-2429/21.01.2014; НСР-12563/05.05.2017 20.05.2017 02.06.2017 Неактивен 2452
Salbutamol 20030690 SALBUTAMOL INHALER, Pressurised inhalation, suspension, 100 mcg/metered actuation - 200 doses, mg, Pack: 1 Glaxo Group Ltd., Обединено Кралство Glaxo Wellcome Production, France; GlaxoSmith Kline Pharmaceuticals S.A. Poland; Glaxo Wellcome S.A., Spain 3.13 0.63 3.76 7% 0.22 3.35 0.67 4.02 20% 0.63 3.98 0.8 4.78 НСР-2429/21.01.2014 05.02.2014 05.02.2014 Неактивен 2452
Salbutamol 20030690 SALBUTAMOL INHALER, Pressurised inhalation, suspension, 100 mcg/metered actuation - 200 doses, mg, Pack: 1 Glaxo Group Ltd., Обединено Кралство Glaxo Wellcome Production, France; GlaxoSmith Kline Pharmaceuticals S.A. Poland; Glaxo Wellcome S.A., Spain 3.72 0.74 4.46 7% 0.26 3.98 0.8 4.78 20% 0.74 4.72 0.94 5.66 КЦРР-2665/20.03.2013 19.04.2013 19.04.2013 Неактивен 2452
Salbutamol II-6771/12.02.2010 SALBUTAMOL INHALER, Pressurised inhalation, suspension, 100 mcg/metered actuation - 200 doses, mg, Pack: 1 Glaxo Group Ltd., Обединено Кралство Glaxo Wellcome Production, France; GlaxoSmithKline Pharmaceuticals SA, Poland; Glaxo Wellcome S.A., Spain 3.89 0.78 4.67 7% 0.27 4.16 0.83 4.99 20% 0.78 4.94 0.99 5.93 КЦ-1683/25.06.2010 15.07.2010 15.07.2010 Неактивен 2452
Salbutamol 20110698 Salbutamol Sandoz, Pressurised inhalation, suspension, 100 mcg/dose - 200 doses, mg, Pack: 1 Sandoz d.d., Словения Aeropharm GmbH, Francois – Mitterrand-Allee 1, 07407 Rudolstadt, Германия 2.89 0.58 3.47 7% 0.2 3.09 0.62 3.71 20% 0.58 3.67 0.73 4.4 НСР-1636/11.11.2013; НСР-11770/17.02.2017; НСР-18772/21.05.2019; НСР-20729/30.01.2020 05.06.2019 02.03.2020 Заличен 2246
Salbutamol 20110698 Salbutamol Sandoz, Pressurised inhalation, suspension, 100 mcg/dose - 200 doses, mg, Pack: 1 Sandoz d.d., Словения Aeropharm GmbH, Francois – Mitterrand-Allee 1, 07407 Rudolstadt, Германия 2.89 0.58 3.47 7% 0.2 3.09 0.62 3.71 20% 0.58 3.67 0.73 4.4 НСР-1636/11.11.2013; НСР-11770/17.02.2017; НСР-18772/21.05.2019 05.06.2019 02.07.2019 Неактивен 2246
Salbutamol 20110698 Salbutamol Sandoz, Pressurised inhalation, suspension, 100 mcg/dose - 200 doses, mg, Pack: 1 Sandoz d.d., Словения Aeropharm GmbH, Francois – Mitterrand-Allee 1, 07407 Rudolstadt, Германия 2.97 0.59 3.56 7% 0.21 3.18 0.64 3.82 20% 0.59 3.77 0.75 4.52 НСР-1636/11.11.2013; НСР-11770/17.02.2017 04.03.2017 02.04.2017 Неактивен 2246
Salbutamol 20110698 Salbutamol Sandoz, Pressurised inhalation, suspension, 100 mcg/dose - 200 doses, mg, Pack: 1 Sandoz d.d., Словения Aeropharm GmbH, Francois – Mitterrand-Allee 1, 07407 Rudolstadt, Германия 3.19 0.64 3.83 7% 0.22 3.41 0.68 4.09 20% 0.64 4.05 0.81 4.86 НСР-1636/11.11.2013 26.11.2013 26.11.2013 Неактивен 2246
Salmeterol, Fluticasone 20170120 Salmeterol and fluticasone Cipla, Pressurised inhalation, suspension, 25 mcg/250 mcg, -, Pack: 120 doses Cipla Europe NV, Белгия S&D Pharma CZ, spol. s r.o, Чешка Република; Cipla (EU) Ltd, Обединено Кралство; Cipla Europe NV, Белгия 35.2 7.04 42.24 4% 1.41 36.61 7.32 43.93 16% 5.63 42.24 8.45 50.69 Промяна на обстоятелства НСР-19751/04.09.2019 НСР-15801/08.06.2018; корекционно решение НСР-16098/05.07.2018; Прот. № 280/30.05.2018 12.09.2018 02.10.2019 Активен 16271
Salmeterol, Fluticasone 20170120 Salmeterol and fluticasone Cipla, Pressurised inhalation, suspension, 25 mcg/250 mcg, -, Pack: 120 doses Cipla (UK) Ltd., Обединено Кралство S&D Pharma CZ, spol. s r.o, Чешка Република; Cipla (EU) Ltd, Обединено Кралство; Cipla Europe NV, Белгия 35.2 7.04 42.24 4% 1.41 36.61 7.32 43.93 16% 5.63 42.24 8.45 50.69 НСР-15801/08.06.2018; корекционно решение НСР-16098/05.07.2018; Прот. № 280/30.05.2018 12.09.2018 02.10.2018 Неактивен 16271
Salmeterol, Fluticasone 20170119 Salmeterol and fluticasone Cipla, Pressurised inhalation, suspension, 25 mcg/125 mcg, -, Pack: 120 doses Cipla Europe NV, Белгия S&D Pharma CZ, spol. s r.o, Чешка Република; Cipla (EU) Ltd, Обединено Кралство; Cipla Europe NV, Белгия 27.83 5.57 33.4 6% 1.67 29.5 5.9 35.4 18% 5.01 34.51 6.9 41.41 Промяна на обстоятелства НСР-19751/04.09.2019 НСР-15801/08.06.2018; корекционно решение НСР-16098/05.07.2018; Прот. № 280/30.05.2018 12.09.2018 02.10.2019 Активен 16272
Salmeterol, Fluticasone 20170119 Salmeterol and fluticasone Cipla, Pressurised inhalation, suspension, 25 mcg/125 mcg, -, Pack: 120 doses Cipla (UK) Ltd., Обединено Кралство S&D Pharma CZ, spol. s r.o, Чешка Република; Cipla (EU) Ltd, Обединено Кралство; Cipla Europe NV, Белгия 27.83 5.57 33.4 6% 1.67 29.5 5.9 35.4 18% 5.01 34.51 6.9 41.41 НСР-15801/08.06.2018; корекционно решение НСР-16098/05.07.2018; Прот. № 280/30.05.2018 12.09.2018 02.10.2018 Неактивен 16272
Mesalazine 20130429 Salofalk, Gastro-resistant prolonged-release granules, 3000, mg, Pack: 30 Dr. Falk Pharma GmbH, Германия Dr. Falk Pharma GmbH, Германия 95.09 19.02 114.11 4% 3.8 98.89 19.78 118.67 16% 15.21 114.1 22.82 136.92 НСР-12135/27.03.2017 11.04.2017 02.05.2017 Активен 15637
Mesalazine 20130427 Salofalk, Gastro-resistant prolonged-release granules, 1000, mg, Pack: 100 Dr. Falk Pharma GmbH, Германия Dr. Falk Pharma GmbH, Германия 111.21 22.24 133.45 4% 4.45 115.66 23.13 138.79 16% 17.79 133.45 26.69 160.14 НСР-5936/01.04.2015. 16.04.2015 16.04.2015 Неактивен 3760
Mesalazine 9600070 SALOFALK, Rectal suspension, 4 g/60 ml, -, Pack: 7 Dr. Falk Pharma GmbH, Германия Dr Falk Pharma GmbH, Германия 46.94 9.39 56.33 4% 1.88 48.82 9.76 58.58 16% 7.51 56.33 11.27 67.6 НСР-6380/03.06.2015.; НСР-20816/13.02.2020 28.02.2020 02.03.2020 Активен 2748
Mesalazine 9600070 SALOFALK, Rectal suspension, 4 g/60 ml, -, Pack: 7 Dr. Falk Pharma GmbH, Германия Dr Falk Pharma GmbH, Germany 48.15 9.63 57.78 4% 1.93 50.08 10.02 60.1 16% 7.7 57.78 11.56 69.34 НСР-6380/03.06.2015. 18.06.2015 18.06.2015 Неактивен 2748
Mesalazine 9600070 SALOFALK, Rectal suspension, 4000, mg, Pack: 7 Dr. Falk Pharma GmbH, Германия Dr Falk Pharma GmbH, Germany 49.58 9.92 59.5 4% 1.98 51.56 10.31 61.87 16% 7.93 59.49 11.9 71.39 НСР-3254/14.04.2014 29.04.2014 29.04.2014 Неактивен 2748
Mesalazine II-0544/05.09.2007 SALOFALK, Rectal suspension, 4000, mg, Pack: 7 Dr. Falk Pharma GmbH, Германия Dr Falk Pharma GmbH, Germany 50.05 10.01 60.06 4% 2 52.05 10.41 62.46 16% 8.01 60.06 12.01 72.07 КЦРР-1054/26.07.2012 10.08.2012 10.08.2012 Неактивен 2748
Showing 13801 to 13826 of 17975 entries
Download link in CSV format: Copy
Download link in JSON format: Copy
Download link in XML format: Copy
 

Моля изчакайте